創傷治療用生物製剤の世界市場:代用皮膚、成長因子

◆英語タイトル:Global Wound Biologics Market 2016-2020
◆商品コード:IRTNTR8401
◆発行会社(調査会社):Technavio
◆発行日:2016年2月3日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、創傷治療用生物製剤の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、創傷治療用生物製剤の世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About Wound Biologics

Mechanical, chemical, thermal, and radiogenic damages can cause cuts, tears, and punctures in the skin, blood vessels, nerves, muscles, internal organs, bones, and joints. Wounds are of two types: acute and chronic. The reparative process in acute wounds occurs at a predictable and expected rate leading to faster healing, while it fails to occur in a predictable amount of time in chronic wounds.
Biologic wound healing process helps re-establish the innate repair mechanisms and may involve the application of biological agents such as plant-derived active biomolecules having antimicrobial, antioxidant, and anti-inflammatory attributes. Biologic dressings prevent evaporative water loss, protein and electrolyte loss, heat loss, and wound contamination. Wound biologics such as granular wound beds permit autolytic debridement for the healing process.

Technavio’s analysts forecast the global wound biologics market to grow at a CAGR of 20.63% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global wound biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:
• Skin substitutes
• Growth factors

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Wound Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Acelity
• Integra LifeSciences
• Organogenesis
• Smith & Nephew

[Other prominent vendors]
• Avita Medical
• BioDlogics
• ConvaTec
• Cytori Therapeutics
• Intercytex
• MacroCure
• Molyncke Health Care
• Nuo Therapeutics
• Osiris Therapeutics
• Regenerys

[Market driver]
• Prevalence of chronic diseases
• For a full, detailed list, view our report

[Market challenge]
• Limited availability of clinical data
• For a full, detailed list, view our report

[Market trend]
• Advances in technology
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global wound biologics market by skin substitutes
• Global wound biologics market by growth factors

PART 07: Geographical segmentation
• Wound biologics market in Americas
• Wound biologics market in EMEA
• Wound biologics market in APAC

PART 08: Market drivers
• Prevalence of chronic diseases
• Availability of different skin substitutes
• Rise in geriatric population

PART 09: Impact of drivers

PART 10: Market challenges
• Limited availability of clinical data
• Availability of alternatives
• Stringent regulatory approval process

PART 11: Impact of drivers and challenges

PART 12: Market trends
• Advances in technology
• Increase in pipeline products
• Demand for combination dressings
• Emergence of new treatment options

PART 13: Vendor landscape
• Competitive scenario
• Key news
• Mergers and acquisitions
• Market share analysis 2015
• Smith & Nephew
• Organogenesis
• Acelity
• Integra LifeSciences
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

PART 15: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Stages of wound healing
Exhibit 03: Types of wounds
Exhibit 04: Global wound biologics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global wound biologics market segmentation by product
Exhibit 07: Global wound biologics market by skin substitutes 2015-2020 ($ millions)
Exhibit 08: Growth factors involved in wound healing
Exhibit 09: Global wound biologics market by growth factors 2015-2020 ($ millions)
Exhibit 10: Global wound biologics market segmentation by geography 2015
Exhibit 11: Wound biologics market in Americas 2015-2020 ($ millions)
Exhibit 12: Wound biologics market in EMEA 2015-2020 ($ millions)
Exhibit 13: Wound biologics market in APAC 2015-2020 ($ millions)
Exhibit 14: Global wound biologics market segmentation by geography 2015-2020 ($ millions)
Exhibit 15: Global wound biologics market segmentation by geography 2015-2020
Exhibit 16: Different commercially available skin substitutes
Exhibit 17: Impact of drivers
Exhibit 18: Impact of drivers and challenges
Exhibit 19: Middle- and late-stage wound biologics in pipeline
Exhibit 20: Ranking of vendors 2015
Exhibit 21: Market share of vendors 2015
Exhibit 22: Smith & Nephew: Business segmentation by revenue 2014
Exhibit 23: Smith & Nephew: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 24: Smith & Nephew: Key takeaways
Exhibit 25: Organogenesis: Key takeaways
Exhibit 26: Acelity: Business segmentation by revenue 2014
Exhibit 27: Acelity: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Acelity: Key takeaways
Exhibit 29: Integra LifeSciences: Key takeaways



【掲載企業】

Acelity, Integra LifeSciences, Organogenesis, Smith & Nephew, Avita Medical, BioDlogics, ConvaTec, Cytori Therapeutics, Intercytex, MacroCure, Molyncke Health Care, Nuo Therapeutics, Osiris Therapeutics, Regenerys.


【レポートのキーワード】

創傷治療、生物製剤、代用皮膚、成長因子

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[創傷治療用生物製剤の世界市場:代用皮膚、成長因子]販売に関する免責事項
★調査レポート[創傷治療用生物製剤の世界市場:代用皮膚、成長因子]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆